[1]
Yu M, Han C, Zhou Q, Liu C, Ding Z. Clinical effects of prophylactic use of phentolamine in patients undergoing pheochromocytoma surgery. Journal of clinical anesthesia. 2018 Feb:44():119. doi: 10.1016/j.jclinane.2017.11.030. Epub 2017 Nov 29
[PubMed PMID: 29195099]
[2]
Sambhunath D, Pankaj K, Usha K. Role of phenoxybenzamine in perioperative clinical practice. Annals of cardiac anaesthesia. 2015 Oct-Dec:18(4):577-8. doi: 10.4103/0971-9784.166473. Epub
[PubMed PMID: 26440247]
[3]
Chan GM, Sharma R, Price D, Hoffman RS, Nelson LS. Phentolamine therapy for cocaine-association acute coronary syndrome (CAACS). Journal of medical toxicology : official journal of the American College of Medical Toxicology. 2006 Sep:2(3):108-11
[PubMed PMID: 18072128]
[4]
Hollander JE, Carter WA, Hoffman RS. Use of phentolamine for cocaine-induced myocardial ischemia. The New England journal of medicine. 1992 Jul 30:327(5):361
[PubMed PMID: 1620184]
[5]
Hollander JE, Henry TD. Evaluation and management of the patient who has cocaine-associated chest pain. Cardiology clinics. 2006 Feb:24(1):103-14
[PubMed PMID: 16326260]
[6]
Duncan C, Omran GJ, Teh J, Davis NF, Bolton DM, Lawrentschuk N. Erectile dysfunction: a global review of intracavernosal injectables. World journal of urology. 2019 Jun:37(6):1007-1014. doi: 10.1007/s00345-019-02727-5. Epub 2019 Mar 20
[PubMed PMID: 30895359]
[7]
Salonia A, Bettocchi C, Boeri L, Capogrosso P, Carvalho J, Cilesiz NC, Cocci A, Corona G, Dimitropoulos K, Gül M, Hatzichristodoulou G, Jones TH, Kadioglu A, Martínez Salamanca JI, Milenkovic U, Modgil V, Russo GI, Serefoglu EC, Tharakan T, Verze P, Minhas S, EAU Working Group on Male Sexual and Reproductive Health. European Association of Urology Guidelines on Sexual and Reproductive Health-2021 Update: Male Sexual Dysfunction. European urology. 2021 Sep:80(3):333-357. doi: 10.1016/j.eururo.2021.06.007. Epub 2021 Jun 26
[PubMed PMID: 34183196]
[8]
Corona G, Cucinotta D, Di Lorenzo G, Ferlin A, Giagulli VA, Gnessi L, Isidori AM, Maiorino MI, Miserendino P, Murrone A, Pivonello R, Rochira V, Sangiorgi GM, Stagno G, Foresta C, Lenzi A, Maggi M, Jannini EA. The Italian Society of Andrology and Sexual Medicine (SIAMS), along with ten other Italian Scientific Societies, guidelines on the diagnosis and management of erectile dysfunction. Journal of endocrinological investigation. 2023 Jun:46(6):1241-1274. doi: 10.1007/s40618-023-02015-5. Epub 2023 Jan 25
[PubMed PMID: 36698034]
[9]
. Alpha 1 Adrenergic Receptor Antagonists. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. 2012:():
[PubMed PMID: 31644028]
[10]
Koudonas A, Anastasiadis A, Tsiakaras S, Langas G, Savvides E, Mykoniatis I, Memmos D, Baniotis P, Vakalopoulos I, de la Rosette J, Dimitriadis G. Overview of current pharmacotherapeutic options in benign prostatic hyperplasia. Expert opinion on pharmacotherapy. 2023 Sep-Dec:24(14):1609-1622. doi: 10.1080/14656566.2023.2237406. Epub 2023 Jul 21
[PubMed PMID: 37448198]
Level 3 (low-level) evidence
[11]
Cui T, Kovell RC, Brooks DC, Terlecki RP. A Urologist's Guide to Ingredients Found in Top-Selling Nutraceuticals for Men's Sexual Health. The journal of sexual medicine. 2015 Nov:12(11):2105-17. doi: 10.1111/jsm.13013. Epub 2015 Nov 3
[PubMed PMID: 26531010]
[12]
Lepor H. Alpha-blockers for the Treatment of Benign Prostatic Hyperplasia. The Urologic clinics of North America. 2016 Aug:43(3):311-23. doi: 10.1016/j.ucl.2016.04.009. Epub
[PubMed PMID: 27476124]
[13]
Porrill SL, Rogers RR, Ballmann CG. Ergogenic and Sympathomimetic Effects of Yohimbine: A Review. Neurology international. 2024 Dec 12:16(6):1837-1848. doi: 10.3390/neurolint16060131. Epub 2024 Dec 12
[PubMed PMID: 39728757]
[14]
Nowacka A, Śniegocka M, Śniegocki M, Ziółkowska E, Bożiłow D, Smuczyński W. Multifaced Nature of Yohimbine-A Promising Therapeutic Potential or a Risk? International journal of molecular sciences. 2024 Nov 29:25(23):. doi: 10.3390/ijms252312856. Epub 2024 Nov 29
[PubMed PMID: 39684567]
[15]
Nash DT. Alpha-adrenergic blockers: mechanism of action, blood pressure control, and effects of lipoprotein metabolism. Clinical cardiology. 1990 Nov:13(11):764-72
[PubMed PMID: 1980236]
[16]
Criscitelli TM. Caring for Patients With Pheochromocytomas in the Perioperative Setting: Earn 1.4 Contact Hours. AORN journal. 2024 Dec:120(6):363-369. doi: 10.1002/aorn.14248. Epub
[PubMed PMID: 39588999]
[17]
Mantica G, Ambrosini F, Drocchi G, Zubko Z, Lo Monaco L, Cafarelli A, Calarco A, Colombo R, De Cobelli O, De Marco F, Ferrari G, Ludovico G, Pecoraro S, Tuzzolo D, Terrone C, Leonardi R. Non-surgical management of BPH: An updated review of current literature and state of the art on natural compounds and medical therapy. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica. 2024 Dec 18:96(4):13098. doi: 10.4081/aiua.2024.13098. Epub 2024 Dec 18
[PubMed PMID: 39692412]
[18]
Wee CB, Kim TH, Tae JH, Choi SY. Efficacy and Safety of Silodosin for the Treatment of Female LUTS: A 12-Week Prospective, Single-Center Study. Lower urinary tract symptoms. 2025 Jan:17(1):e70005. doi: 10.1111/luts.70005. Epub
[PubMed PMID: 39763466]
[19]
Yan H, Li X, Zheng X, Cui Y, Huang J, Cheng Y. Evaluating the safety and effectiveness of α-blockers versus mirabegron for medical expulsive therapy in ureteral calculi: A Systematic review and meta-analysis. PloS one. 2024:19(12):e0315328. doi: 10.1371/journal.pone.0315328. Epub 2024 Dec 27
[PubMed PMID: 39729463]
Level 1 (high-level) evidence
[20]
Campschroer T, Zhu X, Vernooij RW, Lock MT. Alpha-blockers as medical expulsive therapy for ureteral stones. The Cochrane database of systematic reviews. 2018 Apr 5:4(4):CD008509. doi: 10.1002/14651858.CD008509.pub3. Epub 2018 Apr 5
[PubMed PMID: 29620795]
Level 1 (high-level) evidence
[21]
Raison N, Ahmed K, Brunckhorst O, Dasgupta P. Alpha blockers in the management of ureteric lithiasis: A meta-analysis. International journal of clinical practice. 2017 Jan:71(1):. doi: 10.1111/ijcp.12917. Epub
[PubMed PMID: 28097758]
Level 1 (high-level) evidence
[22]
Erdoğan E, Şimşek G, Aşık A, Yaşar H, Şahin C, Sarıca K. Optimal duration of medical expulsive therapy for lower ureteral stones: a critical evaluation. Urolithiasis. 2024 Mar 23:52(1):48. doi: 10.1007/s00240-024-01548-5. Epub 2024 Mar 23
[PubMed PMID: 38520492]
[23]
Ramadhani MZ, Kloping YP, Rahman IA, Yogiswara N, Soebadi MA, Renaldo J. Silodosin as a medical expulsive therapy for distal ureteral stones: A systematic review and meta-analysis. Indian journal of urology : IJU : journal of the Urological Society of India. 2023 Jan-Mar:39(1):21-26. doi: 10.4103/iju.iju_115_22. Epub 2022 Dec 29
[PubMed PMID: 36824112]
Level 1 (high-level) evidence
[24]
Soliman MG, El-Gamal O, El-Gamal S, Abdel Raheem A, Abou-Ramadan A, El-Abd A. Silodosin versus Tamsulosin as Medical Expulsive Therapy for Children with Lower-Third Ureteric Stones: Prospective Randomized Placebo-Controlled Study. Urologia internationalis. 2021:105(7-8):568-573. doi: 10.1159/000513074. Epub 2021 Feb 1
[PubMed PMID: 33524970]
Level 1 (high-level) evidence
[25]
Jung HD, Cho KS, Jun DY, Jeong JY, Moon YJ, Chung DY, Kang DH, Cho S, Lee JY. Silodosin versus Tamsulosin for Medical Expulsive Therapy of Ureteral Stones: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina (Kaunas, Lithuania). 2022 Dec 6:58(12):. doi: 10.3390/medicina58121794. Epub 2022 Dec 6
[PubMed PMID: 36556996]
Level 1 (high-level) evidence
[26]
Fauzan MI, Daryanto B, Budaya TN, Makkaraka MAG, Fakhri M, Rahman IA. Promising selective alpha-1 blocker silodosin as a new therapeutic strategy for premature ejaculation and analysis of its drug adverse effect: A systematic review and meta-analysis of randomized controlled trials. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica. 2024 Nov 11:96(4):12984. doi: 10.4081/aiua.2024.12984. Epub 2024 Nov 11
[PubMed PMID: 39692416]
Level 1 (high-level) evidence
[27]
Naranjo J, Dodd S, Martin YN. Perioperative Management of Pheochromocytoma. Journal of cardiothoracic and vascular anesthesia. 2017 Aug:31(4):1427-1439. doi: 10.1053/j.jvca.2017.02.023. Epub 2017 Feb 4
[PubMed PMID: 28392094]
[28]
Frishman WH, Kotob F. Alpha-adrenergic blocking drugs in clinical medicine. Journal of clinical pharmacology. 1999 Jan:39(1):7-16
[PubMed PMID: 9987696]
[29]
Kaushik J, Sharma R, Goyal S, Dangi M, Jha RK, Singh A. Alpha-adrenergic antagonists and iris dynamics: Challenges and solutions in cataract surgery. BMC ophthalmology. 2024 Oct 3:24(1):431. doi: 10.1186/s12886-024-03705-1. Epub 2024 Oct 3
[PubMed PMID: 39363270]
[30]
Bumbuluț B, Stănilă DM. Floppy iris. How is floppy iris syndrome managed? What do urologists and ophthalmologists say? Romanian journal of ophthalmology. 2024 Jul-Sep:68(3):301-305. doi: 10.22336/rjo.2024.54. Epub
[PubMed PMID: 39464767]
[31]
Yang X, Liu Z, Fan Z, Grzybowski A, Wang N. A narrative review of intraoperative floppy iris syndrome: an update 2020. Annals of translational medicine. 2020 Nov:8(22):1546. doi: 10.21037/atm-20-3214. Epub
[PubMed PMID: 33313291]
Level 3 (low-level) evidence
[32]
Chang DF. Floppy iris syndrome: why BPH treatment can complicate cataract surgery. American family physician. 2009 Jun 15:79(12):1051, 1055-6
[PubMed PMID: 19530635]
[33]
Christou CD, Tsinopoulos I, Ziakas N, Tzamalis A. Intraoperative Floppy Iris Syndrome: Updated Perspectives. Clinical ophthalmology (Auckland, N.Z.). 2020:14():463-471. doi: 10.2147/OPTH.S221094. Epub 2020 Feb 20
[PubMed PMID: 32109982]
Level 3 (low-level) evidence
[34]
McMillian WD, Trombley BJ, Charash WE, Christian RC. Phentolamine continuous infusion in a patient with pheochromocytoma. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2011 Jan 15:68(2):130-4. doi: 10.2146/ajhp090619. Epub
[PubMed PMID: 21200059]
[35]
Suzuki C, Minagawa T, Onuma H, Hiragata S, Kinebuchi Y. α(1)-Blockers as a risk factor for hypotension in combination with oral 5-aminolevulimic acid for photodynamic diagnosis in patients with bladder cancer. International journal of urology : official journal of the Japanese Urological Association. 2025 Jan 3:():. doi: 10.1111/iju.15655. Epub 2025 Jan 3
[PubMed PMID: 39749845]
[36]
Ramirez J. Severe hypotension associated with α blocker tamsulosin. BMJ (Clinical research ed.). 2013 Nov 5:347():f6492. doi: 10.1136/bmj.f6492. Epub 2013 Nov 5
[PubMed PMID: 24192968]
[37]
Arnold AC, Raj SR. Orthostatic Hypotension: A Practical Approach to Investigation and Management. The Canadian journal of cardiology. 2017 Dec:33(12):1725-1728. doi: 10.1016/j.cjca.2017.05.007. Epub 2017 May 17
[PubMed PMID: 28807522]